-- 獨立研究機構CFRA向提供了以下研究報告。 CFRA分析師的觀點摘要如下:我們將12個月目標股價從325美元下調至300美元,相當於2026年每股盈餘預期值的16.6倍,高於LH過去三年15.3倍的平均預期本益比。我們認為,這一下調是基於對醫療保健服務的樂觀預期,包括在醫療資源利用率高的情況下,實驗室檢測量將保持健康增長;此外,鑑於新療法的出現和人口老齡化,LH的增長前景也十分可觀。我們將2026年每股盈餘預期從17.90美元上調至18.03美元,並將2027年每股盈餘預期從19.15美元上調至19.32美元。 2026年第一季收購金額為2.02億美元,其中包括收購Crouse Health旗下紐約中部實驗室聯盟的業務。管理層在第一季財報電話會議上對即將進行的交易充滿信心。 2025 年收購總額達 5.82 億美元。 LH 預計,由於 ACA 增強保費稅收抵免政策近期到期,2026 年診斷業務量將面臨 30 個基點的阻力,我們預計這將導致 ACA 交易所保險覆蓋率大幅下降。
Related Articles
Research Alert: CFRA Maintains Hold Opinion On Shares Of Sonic Automotive Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We increase our 12-month price target by $15 to $85, based on a 2027 P/E of 10.8x, a premium to the stock's 10-year average forward P/E of 9.4x. We increase our adjusted EPS estimates to $7.05 from $7.00 for 2026 and to $7.85 from $7.60 for 2027. Following a much better-than-expected Q1 earnings release, we are raising our estimates and price target, but maintaing our Hold view on the shares. SAH posted Q1 adjusted EPS of $1.62 vs. $1.48 (+9%), well ahead of the $1.40 consensus. Revenue rose 1% to $3.69B ($40M below consensus) but gross margin expanded 70 bps to 16.2% (50 bps ahead of consensus). The quarter benefited from record adjusted EBITDA in the EchoPark segment (used vehicle sales). In our view, this was a solid release, highlighted by much better-than-expected margin performance and a notable increase in share repurchase activity, as SAH reduced its outstanding share count by a staggering 6% during Q1 (more than it bought back in all of 2025). We remain at Hold on valuation and a balanced risk/reward.
Research Alert: CFRA Maintains Buy Rating On Shares Of Tyler Technologies Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our target price to $394 from $402, on a forward P/E of 31x our 2026 EPS projection of $12.71, below its three-year average but above peers on the resilience of the business. We increase our 2026 EPS projection to $12.71 from $12.57 and lift our 2027 EPS forecast to $14.28 from $14.19. TYL reported Q1 2026 revenue of $613.5M, up 8.6% Y/Y, led by exception SaaS revenue acceleration of 23.5% to $222.4M. Transaction-based revenues grew 6.4% to $207.4M. Customers are committing to cloud deployments as modernization efforts are underway and AI use skews toward greater cloud use. We expect this trend to sustain SaaS momentum, increasing our confidence in 20%-plus SaaS growth in the near to medium term. Non-GAAP operating margin expanded 40 bps to 27.2%, while adjusted EBITDA increased 9.3% to $177.3M, benefiting from favorable revenue mix toward higher-margin SaaS and transaction revenues, cloud efficiency gains, and disciplined expense management.
Research Alert: CFRA Maintains Hold Opinion On Shares Of American Water Works Company, Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our 12-month target by $1 to $139, 21.2x our 2027 EPS estimate, a discount to AWK's five-year forward average of 25.1x. We keep our 2026 EPS view at $6.09 and lift 2027 EPS by $0.08 to $6.58. The Q1 EPS miss (-7.4%) is the latest in a series of misses, with seven in the last nine quarters coming in below expectations at an average of -3.1%. Our Hold opinion reflects our moderately balanced view of risks and rewards, particularly around the WTRG merger, though regulatory approval in Kentucky provides some relief to transaction uncertainty. We think higher for longer interest rates will pressure valuations. In the FOMC's most recent meeting, three regional presidents backed the hold on rates but rejected the statement's easing bias, which we interpret as a signal that the Fed's next move may not be a rate cut. We think the acceleration of closing expectations (June 30, 2026 vs. August 2026) for the Nexus Water Group Systems will boost 2026 sales, as we now anticipate 7% Y/Y growth.